Related Experiment Video
Updated: Jan 27, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Are Regulation and Innovation Priorities Serving Public Health Needs?
Christopher-Paul Milne1, Kenneth I Kaitin1
1Tufts Center for the Study of Drug Development, Tufts University, Boston, MA, United States.
Abstract:
A host of challenges confront healthcare authorities worldwide. Topping the list is the demand for innovative new medicines to treat a range of both infectious and non-communicable diseases, while containing spiraling healthcare costs. The challenge is particularly great in therapeutic areas where, despite significant medical need and economic impact, the technical challenges and commercial risk of development serve as disincentives to drug sponsors. These areas include cardiovascular diseases as well as diseases and disorders of the central nervous system. Currently, the development and approval of new active substances, with its disproportionate focus on oncology, is not in alignment with healthcare needs in most geographic regions. In this article, we discuss the origins of this misalignment and suggest various approaches to address healthcare needs going forward.
Related Concept Videos
Self-Serving Bias
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Neural Regulation
Epigenetic Regulation
GTPases and their Regulation
Large G-proteins,...
Health Literacy

